BioTime Inc.

BioTime Inc.
Stock Exchange NYSE
EPS
$0.44
Market Cap
$141.17 M
Shares Outstanding
149.64 M
Public Float
125.51 M
BioTime Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
126.88 M
Public Float
88.71 M

Profile

Address
1010 Atlantic Avenue
Alameda California 94501
United States
Employees -
Website http://www.biotimeinc.com
Updated 07/08/2019
BioTime, Inc. is a clinical-stage biotechnology company, which deals with degenerative diseases. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies.

Financials

View All

Alfred Dennis Kingsley
Chairman
Aditya P. Mohanty
President, Co-Chief Executive Officer & Director